AXA Advisors, LLC Irvine, CA Mar 2012 to Jan 2014 Financial ConsultantUCLA Los Angeles, CA Sep 2009 to Jun 2011 Student Financial Service
Education:
University of California, Los Angeles Los Angeles, CA 2009 to 2011 BA in Business Economic, Political Science, AccountingHong Kong University of Science & Technology, School of Management Hong Kong, Hong Kong Island Jun 2010 to Dec 2010 Education Aboard Program
Skills:
Foreign Language: Proficiency in writing and speaking Mandarin Chinese License: Series 7 and Series 66 securities trading license and advisory investment representative. Computer: Proficiency with Excel, Windows and Mac, PowerPoint, Photoshop, IRS E-file System
Apr 2008 to Dec 2011 Private Chinese Zither InstructorUCLA Students Accounts
Sep 2009 to Jun 2011 Senior ClerkPrivately Alhambra, CA Apr 2008 to Apr 2010 WaitressAlhambra Unified School District Alhambra, CA Sep 2006 to Jun 2007 High School Tutor
Education:
University of California Los Angeles, CA Sep 2009 to Jun 2011 BA in Business EconomicEast Los Angeles College Monterey Park, CA Sep 2007 to Jun 2009 Associate's in Associate
Harry Prince - Los Angeles CA, US Xin Su - Irvine CA, US Lilly Kong - Covina CA, US Celine Ngo, legal representative - Garden Grove CA, US Sergei Arakelov - Santa Monica CA, US Wayne Hogrefe - Lake Forest CA, US
Assignee:
Focus Technologies, Inc. - Cypress CA
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The present invention relates to oxidized fungal antigens and methods of making and using thereof. More particularly, the present invention provides a method for producing an oxidized fungal antigen in culture filtrate. The present invention also provides for the produced oxidized fungal antigens. Devices comprising such oxidized fungal antigens, methods for testing for fungal antibodies using the oxidized fungal antigens and methods for producing anti-fungal antibodies using oxidized fungal antigens are further provided. Antigen detection devices comprising anti-fungal antibodies raised against oxidized fungal antigens produced by the present methods are further provided.
Methods And Compositions For Detecting Herpes Simplex Virus Type 2
Xin Su - Irvine CA, US Lilly Kong - Covina CA, US Wayne Hogrefe - Cypress CA, US
Assignee:
Focus Diagnostics, Inc. - Herndon VA
International Classification:
C12N 5/06
US Classification:
435345, 435 5
Abstract:
The invention provides methods for sensitive and specific detection of anti-HSV-2 antibodies by depletion of cross-reactive (non-specific) antibodies in a biological sample that can lead to a false positive result. The invention also features compositions, including nucleic acids, polypeptides, and kits, for use in the methods of the invention.
Oxidized Fungal Antigens And Methods Of Making And Using Thereof
Harry Prince - Los Angeles CA, US Xin Su - Irvine CA, US Lilly Kong - Covina CA, US Ken Devor - Cypress CA, US Sergei Arakelov - Los Angeles CA, US Wayne Hogrefe - Lake Forest CA, US
International Classification:
G01N033/53 G01N033/569 G01N033/554
US Classification:
435/007320
Abstract:
The present invention relates to oxidized fungal antigens and methods of making and using thereof. More particularly, the present invention provides a method for producing an oxidized fungal antigen in culture filtrate. The present invention also provides for the produced oxidized fungal antigens. Devices comprising such oxidized fungal antigens, methods for testing for fungal antibodies using the oxidized fungal antigens and methods for producing anti-fungal antibodies using oxidized fungal antigens are further provided. Antigen detection devices comprising anti-fungal antibodies raised against oxidized fungal antigens produced by the present methods are further provided.
Methods And Compositions For Detecting Herpes Simplex Virus Type 2
Xin Su - Irvine CA, US Lilly Kong - Covina CA, US Wayne Hogrefe - Lake Forest CA, US
International Classification:
G01N 33/566
US Classification:
436501
Abstract:
The invention provides methods for sensitive and specific detection of anti-HSV-2 antibodies by depletion of cross-reactive (non-specific) antibodies in a biological sample that can lead to a false positive result. The invention also features compositions, including nucleic acids, polypeptides, and kits, for use in the methods of the invention.